Diabeloop Newsroom

Find here all media resources and a dedicated press contact.

brandcom@diabeloop.com

Our Press Releases

Diabeloop study reveals significative sex differences in insulin requirements for Type 1 diabetes patients

Jul 16, 2024

Nouvelle levée de fonds de 15 millions d’euros pour Diabeloop qui annonce la nomination de François Miceli au poste de Président et Directeur Général

Mar 26, 2024

Diabeloop announces collaboration with Novo Nordisk to pursue its interoperability strategy with connected insulin pens – A dedicated clinical program will assess the efficacy of the combined technologies

Mar 21, 2023

Diabeloop: launch of a multi-country clinical study in adolescents and young adults with T1D – Unannounced Meal Management efficacy key to a better quality of life for people with diabetes

Feb 23, 2023

Diabeloop and EOFlow partner to offer a Wearable AID with a Smartphone App

Jan 12, 2023

12-month real-world achievements for Diabeloop’s AID: – 4 million hours of hypoglycemia avoided – Trust in the algorithm leads to fewer meal declarations – Users report a significantly reduced mental load

Sep 21, 2022

Diabeloop, key player in therapeutic AI applied to insulin delivery, announces 70 million euros new financing round to accelerate its international expansion

Jun 02, 2022

All our press releases

Image Library

Erik Huneker co-founder and CTO

Pierre-Yves Benhamou CMO

Cécile Ferracci CCO

Blue logo

White logo

YourLoops

DBLG1 System worn + diagram

DBLG1 System worn

DBLG1 System

DBLG1 System

DBL-4pen

YourLoops

Extended partnership between Diabeloop and Terumo Corporation to develop and commercialize AID solutions in Europe

15 February 2022 https://www.mpo-mag.com/contents/view_breaking-news/2022-02-15/terumo-and-diabeloop-partner-to-expand-diabetes-care-offerings/

Diabeloop adapts their AI algorithms to insulin pens

12 April 2022 https://www.massdevice.com/diabeloop-announces-integration-of-insulin-automatization-software-for-use-with-insulin-pens/

Diabeloop rounds up 70 million euros to accelerate its international expansion

02 June 2022 https://www.fiercebiotech.com/medtech/diabeloop-rounds-eu70m-take-ai-powered-insulin-delivery-tech-global

Conclusion of new global development and commercial agreements with SOOIL Development Company

03 June 2022 https://www.massdevice.com/diabeloop-sooil-automated-insulin-diabetes/

Diabeloop completes a 70 million euros Series C to support its hyper growth

04 June 2022 https://www.g-medtech.com/news/diabeloop-closes-e70m-series-c-financing-led-by-lbo-france/

Diabeloop and EOFlow enter into partnership agreements to co-develop a wearable AID solution with a smartphone app

12 January 2023 https://aithority.com/technology/diabeloop-and-eoflow-partner-to-offer-a-wearable-aid-with-a-smartphone-app/?utm_source=hootsuite&utm_medium=twitter&utm_term=aithority&utm_content=53596a22-1ba5-4334-9ba7-34ce94c9e14f&utm_campaign=Organic

Connected insulin pens: Diabeloop announces a new collaboration with Novo Nordisk

21 March 2023 https://www.contractpharma.com/contents/view_breaking-news/2023-03-21/diabeloop-novo-nordisk-partner-on-next-gen-insulin-pens/

They talk about us

Extended partnership between Diabeloop and Terumo Corporation to develop and commercialize AID solutions in Europe

15 February 2022